325 related articles for article (PubMed ID: 30382085)
1. Cloaking nanoparticles with protein corona shield for targeted drug delivery.
Oh JY; Kim HS; Palanikumar L; Go EM; Jana B; Park SA; Kim HY; Kim K; Seo JK; Kwak SK; Kim C; Kang S; Ryu JH
Nat Commun; 2018 Oct; 9(1):4548. PubMed ID: 30382085
[TBL] [Abstract][Full Text] [Related]
2. Biological effects of formation of protein corona onto nanoparticles.
Mishra RK; Ahmad A; Vyawahare A; Alam P; Khan TH; Khan R
Int J Biol Macromol; 2021 Apr; 175():1-18. PubMed ID: 33508360
[TBL] [Abstract][Full Text] [Related]
3. The Protein Corona of Plant Virus Nanoparticles Influences their Dispersion Properties, Cellular Interactions, and In Vivo Fates.
Pitek AS; Wen AM; Shukla S; Steinmetz NF
Small; 2016 Apr; 12(13):1758-69. PubMed ID: 26853911
[TBL] [Abstract][Full Text] [Related]
4. Protein Corona-Enabled Systemic Delivery and Targeting of Nanoparticles.
Chen D; Ganesh S; Wang W; Amiji M
AAPS J; 2020 Jun; 22(4):83. PubMed ID: 32495039
[TBL] [Abstract][Full Text] [Related]
5. Concentration-dependent protein adsorption at the nano-bio interfaces of polymeric nanoparticles and serum proteins.
Zhang TX; Zhu GY; Lu BY; Zhang CL; Peng Q
Nanomedicine (Lond); 2017 Nov; 12(22):2757-2769. PubMed ID: 29017387
[TBL] [Abstract][Full Text] [Related]
6. Artificial apolipoprotein corona enables nanoparticle brain targeting.
Dal Magro R; Albertini B; Beretta S; Rigolio R; Donzelli E; Chiorazzi A; Ricci M; Blasi P; Sancini G
Nanomedicine; 2018 Feb; 14(2):429-438. PubMed ID: 29157979
[TBL] [Abstract][Full Text] [Related]
7. The role of surface chemistry in serum protein corona-mediated cellular delivery and gene silencing with lipid nanoparticles.
Chen D; Ganesh S; Wang W; Amiji M
Nanoscale; 2019 May; 11(18):8760-8775. PubMed ID: 30793730
[TBL] [Abstract][Full Text] [Related]
8. Plasma protein adsorption and biological identity of systemically administered nanoparticles.
Chen D; Ganesh S; Wang W; Amiji M
Nanomedicine (Lond); 2017 Sep; 12(17):2113-2135. PubMed ID: 28805542
[TBL] [Abstract][Full Text] [Related]
9. Tailored Dual PEGylation of Inorganic Porous Nanocarriers for Extremely Long Blood Circulation in Vivo.
Nissinen T; Näkki S; Laakso H; Kučiauskas D; Kaupinis A; Kettunen MI; Liimatainen T; Hyvönen M; Valius M; Gröhn O; Lehto VP
ACS Appl Mater Interfaces; 2016 Dec; 8(48):32723-32731. PubMed ID: 27934159
[TBL] [Abstract][Full Text] [Related]
10. Controlling the Stealth Effect of Nanocarriers through Understanding the Protein Corona.
Schöttler S; Landfester K; Mailänder V
Angew Chem Int Ed Engl; 2016 Jul; 55(31):8806-15. PubMed ID: 27303916
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle-Protein Interaction: The Significance and Role of Protein Corona.
Ahsan SM; Rao CM; Ahmad MF
Adv Exp Med Biol; 2018; 1048():175-198. PubMed ID: 29453539
[TBL] [Abstract][Full Text] [Related]
12. Visualization of the protein corona: towards a biomolecular understanding of nanoparticle-cell-interactions.
Kokkinopoulou M; Simon J; Landfester K; Mailänder V; Lieberwirth I
Nanoscale; 2017 Jun; 9(25):8858-8870. PubMed ID: 28632260
[TBL] [Abstract][Full Text] [Related]
13. Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity.
Lee YK; Choi EJ; Webster TJ; Kim SH; Khang D
Int J Nanomedicine; 2015; 10():97-113. PubMed ID: 25565807
[TBL] [Abstract][Full Text] [Related]
14. Protein corona variation in nanoparticles revisited: A dynamic grouping strategy.
Rezaei G; Daghighi SM; Haririan I; Yousefi I; Raoufi M; Rezaee F; Dinarvand R
Colloids Surf B Biointerfaces; 2019 Jul; 179():505-516. PubMed ID: 31009853
[TBL] [Abstract][Full Text] [Related]
15. Bypassing Protein Corona Issue on Active Targeting: Zwitterionic Coatings Dictate Specific Interactions of Targeting Moieties and Cell Receptors.
Safavi-Sohi R; Maghari S; Raoufi M; Jalali SA; Hajipour MJ; Ghassempour A; Mahmoudi M
ACS Appl Mater Interfaces; 2016 Sep; 8(35):22808-18. PubMed ID: 27526263
[TBL] [Abstract][Full Text] [Related]
16. Amphoteric natural starch-coated polymer nanoparticles with excellent protein corona-free and targeting properties.
Huang B; Yang Z; Fang S; Li Y; Zhong Z; Zheng R; Zhang J; Wang H; Wang S; Zou Q; Wu L
Nanoscale; 2020 Mar; 12(10):5834-5847. PubMed ID: 32068222
[TBL] [Abstract][Full Text] [Related]
17. Effects of the protein corona on liposome-liposome and liposome-cell interactions.
Corbo C; Molinaro R; Taraballi F; Toledano Furman NE; Sherman MB; Parodi A; Salvatore F; Tasciotti E
Int J Nanomedicine; 2016; 11():3049-63. PubMed ID: 27445473
[TBL] [Abstract][Full Text] [Related]
18. The "sweet" side of the protein corona: effects of glycosylation on nanoparticle-cell interactions.
Wan S; Kelly PM; Mahon E; Stöckmann H; Rudd PM; Caruso F; Dawson KA; Yan Y; Monopoli MP
ACS Nano; 2015 Feb; 9(2):2157-66. PubMed ID: 25599105
[TBL] [Abstract][Full Text] [Related]
19. Identification of Receptor Binding to the Biomolecular Corona of Nanoparticles.
Lara S; Alnasser F; Polo E; Garry D; Lo Giudice MC; Hristov DR; Rocks L; Salvati A; Yan Y; Dawson KA
ACS Nano; 2017 Feb; 11(2):1884-1893. PubMed ID: 28112950
[TBL] [Abstract][Full Text] [Related]
20. Differential uptake of nanoparticles by human M1 and M2 polarized macrophages: protein corona as a critical determinant.
Binnemars-Postma KA; Ten Hoopen HW; Storm G; Prakash J
Nanomedicine (Lond); 2016 Nov; 11(22):2889-2902. PubMed ID: 27780415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
